TCL Archive Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease By Cancer History Project February 22, 2013
TCL Archive Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard By Cancer History Project February 22, 2013
TCL Archive Avastin Increases Overall Survival 3.7 Months By Cancer History Project February 22, 2013
TCL Archive First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma By Cancer History Project February 22, 2013
TCL Archive Phase III Trial of ThermoDox Fails to Meet Primary Endpoint By Cancer History Project February 22, 2013
TCL Archive Neulasta Reduces Incidence Of Febrile Neutropenia By Cancer History Project February 22, 2013
TCL Archive Tivozanib Does Not Improve OS Compared to Sorafenib By Cancer History Project February 22, 2013
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
